Certain Series B Non-Voting, Convertible Preferred Stock of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 27-MAY-2024.
Details:
The executive officers and directors have agreed, for a period of three months from the date of this prospectus supplement.